Photosensitivity amongst Thai patients receiving voriconazole or posaconazole Skin cancer amongst Thai patients receiving voriconazole or posaconazole voriconazole, posaconazole, photosensitivity, squamous cell carcinoma
Conditions
Interventions
Patient receiving voriconazole or posaconazole at King Chulalongkorn Memorial Hospital more than 7 days during 2012-2022,Patient receiving itraconazole or fluconazole at King Chulalongkorn Memorial H
Other,Other
Patient receiving voriconazole or posaconazole,Control
Sponsors
Graduate Affairs, Faculty of Medicine, Chulalongkorn Univerisity
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients receiving voriconazole or posaconazole at King Chulalongkorn Memorial Hospital more than 7 days during 2012-2022 2.Controls group, age, sex, Fitzpatrick skin type, and organ transplant profile-matched controls receving fluconazole or itraconazole at King Chulalongkorn Memorial Hospital during 2012-2022
Exclusion criteria
Exclusion criteria: 1.No data regarding voriconazole level available 2.Clinically unstable patient and unable to follow investigator's appointment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of photosensitivity and skin cancer one time Ratio of patients with interested outcome and all patients in the study | — |
Secondary
| Measure | Time frame |
|---|---|
| Phototesting result amongst patient receiving voriconazole or posaconazole one time Phototesting,Risk factors of photosensitivity and skin cancer amongst patient receiving voriconazole and posaconazole One time Patient reported history using a questionnaire interview | — |
Countries
Thailand
Contacts
Public ContactEinapak Boontaveeyuwat
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed